Our two proprietary technology platforms work to identify and deliver antigens to the immune system
YGNITE
YGION has developed the AI-driven YGNITE™ bioinformatics pipeline for fast and effective identification of relevant targets for immunotherapy development. The YGNITE platform combines a set of proprietary, internally developed bioinformatics modules that are integrated to identify relevant immunogens.
YGNITE™ enables identification of highly unique but safe patient-specific antigens for immunotherapy
CARGONAUT
CARGONAUT™ is a proprietary immune-modulating carrier molecule, developed to deliver carefully selected antigens directly to antigen-presenting cells. Simultaneous activation of these antigen-presenting cells results in efficient cross-presentation and activation of the immune system.
Instead of broadly stimulating the immune system, this sophisticated deliver-and-stimulate-approach ensures a precise and effective immune response.
By leveraging the patient’s own immune mechanisms, our approach promotes selective recognition and elimination of tumor cells, with the goal of achieving durable anti‑tumor activity.
